The Centers for Medicare & Medicaid Services (CMS) has issued a decision memo stating that the national coverage determination manual will be changed to remove the current absolute restriction of coverage to ‘only one’ FDG PET scan, and local Medicare administrative contractors will have discretion to cover (or not cover) any additional FDG PET scan for initial treatment strategy in solid tumors and myeloma.
PHILADELPHIA—While most cancer therapies deliver a uniform amount of radiation to the tumor as a whole, cancer masses are not homogenous. Researchers at the University of Wisconsin, Madison, discovered that most of the head and neck tumors in their study contained three statistically different subpopulations with distinct profiles, and they presented the study July 19 at the annual meeting of the American Association of Physicists in Medicine (AAPM).
Written by Chris Kaiser
PHILADELPHIA—CT perfusion assessment of rectal cancer after hypofractionated radiotherapy correlated well with FDG-PET assessment and showed an increased tumor perfusion. Researchers suggest the increased vascularity could improve the bioavailability of cytotoxic agents in rectal tumors, often administered early after radiotherapy treatment, according to a poster presentation at the annual meeting of the American Association of Physicists in Medicine (AAPM).
Syntermed launched NeuroQ version 3.5, a nuclear medicine quantitative software platform for analysis and image display of brain FDG-PET scans at the Alzheimer’s Association 2010 international conference this week in Honolulu.
Written by Lisa Fratt
SALT LAKE CITY--Optical imaging techniques may add to the molecular imaging arsenal and facilitate early detection of cancer, according to research presented at the SNM annual meeting this week.
By quantifying microbubble retention within carotid plaque, late-phase contrast-enhanced ultrasound (US) depicts clear differences between groups of subjects with plaque ipsilaterial to symptoms and asymptomatic plaques, according to a study in the May issue of Radiology.
18F-FDG PET identified the average increase amyloid-beta plaques among individuals whose mothers had been diagnosed with Alzheimer’s disease compared to others with no family history of dementia, according to research findings published online March 15 in the Proceedings of the National Academy of Sciences.
Pre-treatment maximal standardized uptake value (SUVmax) from FDG PET imaging of the primary tumor in head and neck squamous cell carcinoma patients is a strong predictor of prognosis, while pre-treatment SUVmax of the lymphadenopathy is significantly associated with distant metastasis, according to a study presented on Feb. 26 at the Multidisciplinary Head and Neck Cancer Symposium in Chandler, Ariz.
FDG-PET and PET/CT may be valuable diagnostic tools for the evaluation of children with fever of unknown origin and unexplained signs of inflammation, according to a study published in the January issue of European Journal of Nuclear Medicine and Molecular Imaging.
FDG-PET brain imaging has shown that cocaine abusers may retain some ability to inhibit craving which may be therapeutically beneficial in addiction, according to research published online Nov. 18 in NeuroImage.
Seven medical imaging societies have written a joint letter asking the Centers for Medicare and Medicaid Services (CMS) to provide coverage for two FDG PET scans for initial patient treatment evaluation, as opposed to the one scan CMS now covers.
FDG PET and CT are equivalent in upstaging in patients with melanoma; however, FDG PET detected more metastatic sites, especially bone and subcutaneous, according to a study in the Oct. 1 issue of the Journal of Clinical Oncology.
Research presented at the 2009 European Association of Nuclear Medicine (EANM) conference in Barcelona, Spain, suggests that FDG PET is useful in monitoring response to antimycobacterial treatment in patients with pulmonary tuberculosis and can direct alternative therapy in case of resistant disease.
Written by Sarah Lamberti
As personalized medicine attempts to revolutionize healthcare, giving patients access to tailored medical care, PET/CT is emerging with the promise of personalized therapies for oncology, including women’s cancers to provide the right patient with the right treatment at the right time.
|